BIOMAT Database Logo BIOMAT Database Logo

Influence of autonomic tone on the filtered QRS duration from signal averaged electrocardiograms in healthy volunteers. 2000

M Nakagawa, and T Iwao, and H Abe, and S Ishida, and N Takahashi, and T Fujino, and H Yonemochi, and T Saikawa, and M Ito
Department of Laboratory Medicine, Oita Medical University, Japan.

We recently reported that signal averaged electrocardiograms (SAECG) measurements possess a circadian rhythm and are closely related to heart rate or heart rate variability in healthy volunteers. This study determines the influence of autonomic tone on the filtered QRS (f-QRS) duration from SAECG by using pharmacologic autonomic blockade and exercise in healthy volunteers. Eleven healthy male volunteers were studied. Three protocols were designed to study the effects of exercise (Ex) under control conditions, beta adrenergic blockade or double blockade. SAECGs and heart rate variability (LF and HF: low and high frequency power, LF/HF ratio) were determined from Holter recordings. Ex significantly decreased the f-QRS duration and HF and significantly increased heart rate and LF/HF. Ex during beta adrenergic blockade significantly increased heart rate and decreased f-QRS duration and HF, but did not change LF/HF. Ex during double blockade did not affect the f-QRS duration, HF, or LF/HF. The changes in f-QRS duration induced during Ex, autonomic blockade, or both were inversely correlated with changes in heart rate and LF/HF and positively correlated with changes in HF. These data suggest that f-QRS duration in healthy subjects is shortened by Ex with increased sympathetic tone or decreased parasympathetic tone or the combination.

UI MeSH Term Description Entries
D008297 Male Males
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001341 Autonomic Nervous System The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS. Vegetative Nervous System,Visceral Nervous System,Autonomic Nervous Systems,Nervous System, Autonomic,Nervous System, Vegetative,Nervous System, Visceral,Nervous Systems, Autonomic,Nervous Systems, Vegetative,Nervous Systems, Visceral,System, Autonomic Nervous,System, Vegetative Nervous,System, Visceral Nervous,Systems, Autonomic Nervous,Systems, Vegetative Nervous,Systems, Visceral Nervous,Vegetative Nervous Systems,Visceral Nervous Systems
D012815 Signal Processing, Computer-Assisted Computer-assisted processing of electric, ultrasonic, or electronic signals to interpret function and activity. Digital Signal Processing,Signal Interpretation, Computer-Assisted,Signal Processing, Digital,Computer-Assisted Signal Interpretation,Computer-Assisted Signal Interpretations,Computer-Assisted Signal Processing,Interpretation, Computer-Assisted Signal,Interpretations, Computer-Assisted Signal,Signal Interpretation, Computer Assisted,Signal Interpretations, Computer-Assisted,Signal Processing, Computer Assisted

Related Publications

M Nakagawa, and T Iwao, and H Abe, and S Ishida, and N Takahashi, and T Fujino, and H Yonemochi, and T Saikawa, and M Ito
Effects of upright posture on filtered QRS parameter of the signal-averaged electrocardiogram in healthy volunteers.
December 1997, American heart journal,
M Nakagawa, and T Iwao, and H Abe, and S Ishida, and N Takahashi, and T Fujino, and H Yonemochi, and T Saikawa, and M Ito
[Influence of the duration of myocardial infarction on QRS duration measured by signal averaged electrocardiography].
November 1995, Archives des maladies du coeur et des vaisseaux,
M Nakagawa, and T Iwao, and H Abe, and S Ishida, and N Takahashi, and T Fujino, and H Yonemochi, and T Saikawa, and M Ito
Filtered QRS duration on signal-averaged electrocardiography predicts inducibility of ventricular tachycardia in arrhythmogenic right ventricle dysplasia.
October 2003, Pacing and clinical electrophysiology : PACE,
M Nakagawa, and T Iwao, and H Abe, and S Ishida, and N Takahashi, and T Fujino, and H Yonemochi, and T Saikawa, and M Ito
Gender-related differences on signal-averaged electrocardiograms in healthy subjects.
November 1995, The American journal of cardiology,
M Nakagawa, and T Iwao, and H Abe, and S Ishida, and N Takahashi, and T Fujino, and H Yonemochi, and T Saikawa, and M Ito
Narrowing filtered QRS duration on signal-averaged electrocardiogram predicts outcomes in cardiac resynchronization therapy patients with nonischemic heart failure.
May 2018, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc,
M Nakagawa, and T Iwao, and H Abe, and S Ishida, and N Takahashi, and T Fujino, and H Yonemochi, and T Saikawa, and M Ito
Time domain signal-averaged electrocardiogram in predicting arrhythmic events after myocardial infarction: role of the duration of the filtered QRS complex.
December 1996, Cardiologia (Rome, Italy),
M Nakagawa, and T Iwao, and H Abe, and S Ishida, and N Takahashi, and T Fujino, and H Yonemochi, and T Saikawa, and M Ito
Performance of the signal-averaged electrocardiogram: relation to baseline QRS duration.
May 1995, American heart journal,
M Nakagawa, and T Iwao, and H Abe, and S Ishida, and N Takahashi, and T Fujino, and H Yonemochi, and T Saikawa, and M Ito
Influence of autonomic tone on QT interval duration.
October 1997, Cardiologia (Rome, Italy),
M Nakagawa, and T Iwao, and H Abe, and S Ishida, and N Takahashi, and T Fujino, and H Yonemochi, and T Saikawa, and M Ito
Signal-averaged electrocardiography of the terminal QRS in healthy young adults.
November 1989, Pacing and clinical electrophysiology : PACE,
M Nakagawa, and T Iwao, and H Abe, and S Ishida, and N Takahashi, and T Fujino, and H Yonemochi, and T Saikawa, and M Ito
Effect of body characteristics on the variables of signal-averaged electrocardiograms in healthy subjects.
May 1994, Chest,
Copied contents to your clipboard!